153 related articles for article (PubMed ID: 24449770)
1. Population pharmacokinetic assessment of the effect of food on piperaquine bioavailability in patients with uncomplicated malaria.
Tarning J; Lindegardh N; Lwin KM; Annerberg A; Kiricharoen L; Ashley E; White NJ; Nosten F; Day NP
Antimicrob Agents Chemother; 2014; 58(4):2052-8. PubMed ID: 24449770
[TBL] [Abstract][Full Text] [Related]
2. A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Sudan.
Hoglund RM; Adam I; Hanpithakpong W; Ashton M; Lindegardh N; Day NP; White NJ; Nosten F; Tarning J
Malar J; 2012 Nov; 11():398. PubMed ID: 23190801
[TBL] [Abstract][Full Text] [Related]
3. Population Pharmacokinetic Properties of Piperaquine in Falciparum Malaria: An Individual Participant Data Meta-Analysis.
Hoglund RM; Workman L; Edstein MD; Thanh NX; Quang NN; Zongo I; Ouedraogo JB; Borrmann S; Mwai L; Nsanzabana C; Price RN; Dahal P; Sambol NC; Parikh S; Nosten F; Ashley EA; Phyo AP; Lwin KM; McGready R; Day NP; Guerin PJ; White NJ; Barnes KI; Tarning J
PLoS Med; 2017 Jan; 14(1):e1002212. PubMed ID: 28072872
[TBL] [Abstract][Full Text] [Related]
4. Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand.
Tarning J; Ashley EA; Lindegardh N; Stepniewska K; Phaiphun L; Day NP; McGready R; Ashton M; Nosten F; White NJ
Antimicrob Agents Chemother; 2008 Mar; 52(3):1052-61. PubMed ID: 18180343
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malaria.
Rijken MJ; McGready R; Phyo AP; Lindegardh N; Tarning J; Laochan N; Than HH; Mu O; Win AK; Singhasivanon P; White N; Nosten F
Antimicrob Agents Chemother; 2011 Dec; 55(12):5500-6. PubMed ID: 21947392
[TBL] [Abstract][Full Text] [Related]
6. A small amount of fat does not affect piperaquine exposure in patients with malaria.
Annerberg A; Lwin KM; Lindegardh N; Khrutsawadchai S; Ashley E; Day NP; Singhasivanon P; Tarning J; White NJ; Nosten F
Antimicrob Agents Chemother; 2011 Sep; 55(9):3971-6. PubMed ID: 21709087
[TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetics of piperaquine in adults and children with uncomplicated falciparum or vivax malaria.
Hung TY; Davis TM; Ilett KF; Karunajeewa H; Hewitt S; Denis MB; Lim C; Socheat D
Br J Clin Pharmacol; 2004 Mar; 57(3):253-62. PubMed ID: 14998421
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and ex vivo pharmacodynamic antimalarial activity of dihydroartemisinin-piperaquine in patients with uncomplicated falciparum malaria in Vietnam.
Nguyen DV; Nguyen QP; Nguyen ND; Le TT; Nguyen TD; Dinh DN; Nguyen TX; Bui D; Chavchich M; Edstein MD
Antimicrob Agents Chemother; 2009 Aug; 53(8):3534-7. PubMed ID: 19528277
[TBL] [Abstract][Full Text] [Related]
9. Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria.
Tarning J; Rijken MJ; McGready R; Phyo AP; Hanpithakpong W; Day NP; White NJ; Nosten F; Lindegardh N
Antimicrob Agents Chemother; 2012 Apr; 56(4):1997-2007. PubMed ID: 22252822
[TBL] [Abstract][Full Text] [Related]
10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
11. Effect of food on the pharmacokinetics of piperaquine and dihydroartemisinin.
Reuter SE; Evans AM; Shakib S; Lungershausen Y; Francis B; Valentini G; Bacchieri A; Ubben D; Pace S
Clin Drug Investig; 2015 Sep; 35(9):559-67. PubMed ID: 26293519
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetics, tolerability, and safety of dihydroartemisinin-piperaquine and sulfadoxine-pyrimethamine-piperaquine in pregnant and nonpregnant Papua New Guinean women.
Benjamin JM; Moore BR; Salman S; Page-Sharp M; Tawat S; Yadi G; Lorry L; Siba PM; Batty KT; Robinson LJ; Mueller I; Davis TM
Antimicrob Agents Chemother; 2015 Jul; 59(7):4260-71. PubMed ID: 25963981
[TBL] [Abstract][Full Text] [Related]
13. Semimechanistic Pharmacokinetic and Pharmacodynamic Modeling of Piperaquine in a Volunteer Infection Study with Plasmodium falciparum Blood-Stage Malaria.
Wattanakul T; Baker M; Mohrle J; McWhinney B; Hoglund RM; McCarthy JS; Tarning J
Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33468477
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria.
Tarning J; Zongo I; Somé FA; Rouamba N; Parikh S; Rosenthal PJ; Hanpithakpong W; Jongrak N; Day NP; White NJ; Nosten F; Ouedraogo JB; Lindegardh N
Clin Pharmacol Ther; 2012 Mar; 91(3):497-505. PubMed ID: 22258469
[TBL] [Abstract][Full Text] [Related]
15. Population Pharmacokinetics of Piperaquine in Young Ugandan Children Treated With Dihydroartemisinin-Piperaquine for Uncomplicated Malaria.
Sambol NC; Yan L; Creek DJ; McCormack SA; Arinaitwe E; Bigira V; Wanzira H; Kakuru A; Tappero JW; Lindegardh N; Tarning J; Nosten F; Aweeka FT; Parikh S
Clin Pharmacol Ther; 2015 Jul; 98(1):87-95. PubMed ID: 25732044
[TBL] [Abstract][Full Text] [Related]
16. Piperaquine Pharmacokinetics during Intermittent Preventive Treatment for Malaria in Pregnancy.
Chotsiri P; Gutman JR; Ahmed R; Poespoprodjo JR; Syafruddin D; Khairallah C; Asih PBS; L'lanziva A; Otieno K; Kariuki S; Ouma P; Were V; Katana A; Price RN; Desai M; Ter Kuile FO; Tarning J
Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33361303
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria.
Adam I; Tarning J; Lindegardh N; Mahgoub H; McGready R; Nosten F
Am J Trop Med Hyg; 2012 Jul; 87(1):35-40. PubMed ID: 22764289
[TBL] [Abstract][Full Text] [Related]
18. A randomised, double-blind clinical phase II trial of the efficacy, safety, tolerability and pharmacokinetics of a single dose combination treatment with artefenomel and piperaquine in adults and children with uncomplicated Plasmodium falciparum malaria.
Macintyre F; Adoke Y; Tiono AB; Duong TT; Mombo-Ngoma G; Bouyou-Akotet M; Tinto H; Bassat Q; Issifou S; Adamy M; Demarest H; Duparc S; Leroy D; Laurijssens BE; Biguenet S; Kibuuka A; Tshefu AK; Smith M; Foster C; Leipoldt I; Kremsner PG; Phuc BQ; Ouedraogo A; Ramharter M;
BMC Med; 2017 Oct; 15(1):181. PubMed ID: 28988541
[TBL] [Abstract][Full Text] [Related]
19. Piperaquine Population Pharmacokinetics and Cardiac Safety in Cambodia.
Vanachayangkul P; Lon C; Spring M; Sok S; Ta-Aksorn W; Kodchakorn C; Pann ST; Chann S; Ittiverakul M; Sriwichai S; Buathong N; Kuntawunginn W; So M; Youdaline T; Milner E; Wojnarski M; Lanteri C; Manning J; Prom S; Haigney M; Cantilena L; Saunders D
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28193647
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics and electrocardiographic effects of dihydroartemisinin-piperaquine in healthy volunteers.
Chotsiri P; Wattanakul T; Hoglund RM; Hanboonkunupakarn B; Pukrittayakamee S; Blessborn D; Jittamala P; White NJ; Day NPJ; Tarning J
Br J Clin Pharmacol; 2017 Dec; 83(12):2752-2766. PubMed ID: 28695570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
